Shukun Technology closes RMB200m Series B1 round

Medical artificial intelligence company Shukun Technology announced the completion of 200 million yuan in Series B1 round of financing. This round was led by BOC International with participation from CCB International Healthcare Fund, existing investors China Creation Ventures and Huagai Capital.

Medical artificial intelligence company Shukun Technology announced the completion of 200 million yuan in Series B1 round of financing. This round was led by BOC International with participation from CCB International Healthcare Fund, existing investors China Creation Ventures and Huagai Capital.

Shukun Technology will use the proceeds to expand its coverage of clinical scenarios such as heart, nervous system and tumors, and to accelerate the application of artificial intelligence technology in all levels of hospitals, especially in improving the medical level of grass-roots clinics.

Founded in 2017, Shukun Technology uses machine learning and AI technology to improve the diagnostic experience in hospitals. It combines expert intelligence and machine intelligence to increase the level and efficiency of medical service for both doctors and patients.

So far, Shukun Technology has cooperated with hundreds of top hospitals, and has also signed strategic cooperation agreements with medical equipment manufacturers such as GE Healthcare and Philips Healthcare.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/17/shukun-technology-closes-rmb200m-series-b1-round/.

Leave a Reply

Please Login to Comment